Johnson & Johnson Q3 FY2024 Earnings Call

Johnson & Johnson (JNJ)

Earnings Call FY2024 Q3 Call date: 2024-01-23 Concluded

Quarter scorecard

Revenue

$21.35B

+6.8% YoY

Diluted EPS

$10.21

+507.7% YoY

Gross margin

69.1%

+0.0 pp YoY

Net income

$26.03B

+483.8% YoY

Innovative Medicine $13.89B

+5.1%

MedTech $7.46B

+10%

Buybacks (derived)

$920.00M